ASX:RHY

Rhythm Biosciences (RHY) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free RHY Stock Alerts

Compare

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: N/A
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Rhythm Biosciences alerts:

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

About Rhythm Biosciences Stock (ASX:RHY)

Rhythm Biosciences Limited, engages in developing and commercializing medical diagnostics technology in Australia and internationally. It develops ColoSTAT, a blood test for the early detection of colorectal cancer. The company was incorporated in 2017 and is headquartered in Parkville, Australia.

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

RHY Stock News Headlines

April 17, 2024 | msn.com

Will and Jada Pinkett Smith make appearance at Coachella together to cheer on daughter Willow

April 14, 2024 | msn.com

Dr Boreham’s Crucible: Is Breastest the bestest breast test? Bcal’s close to finding out

April 19, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

April 1, 2024 | msn.com

Pulse Biosciences, Inc. (NASDAQ:PLSE) Q4 2023 Earnings Call Transcript

March 27, 2024 | finance.yahoo.com

One Rhythm Biosciences Insider Raised Their Stake In The Previous Year

February 1, 2024 | yahoo.com

Listen to an Exclusive Track From The Underdoggs by Joseph Shirley

January 25, 2024 | yahoo.com

Iconic Phoenix music club turns to GoFundMe to survive: 'We could use the community's help'

December 13, 2023 | finance.yahoo.com

Rhythm Biosciences Limited (RHY.AX)

April 19, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

November 30, 2023 | benzinga.com

Catheter Precision Inc. (NYSE American: VTAK) Spotlighted in "Cardiac Rhythm News" for Revolutionary Advances in Cardiac Treatment"

November 23, 2023 | msn.com

ASX Health Stocks: Rhythm Bio says new research in lung cancer is warranted after this finding

November 18, 2023 | afr.com

Rhythm Biosciences Limited

May 12, 2022 | fool.com.au

Rhythm Biosciences share price lifts 5% on TGA news

May 3, 2022 | investing.com

Rhythm Biosciences Ltd (RHY)

See More Headlines

Receive RHY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Rhythm Biosciences and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: ASX
Sector: Medical
Industry: Diagnostics & Research
Sub-Industry: N/A
Current Symbol: ASX:RHY
CUSIP: N/A
CIK: N/A
Web: www.rhythmbio.com
Phone: 61 3 8256 2880
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): A($0.04)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-8,630,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -171.97%
Return on Assets: -91.64%

Debt

Debt-to-Equity Ratio: 3.13
Current Ratio: 2.05
Quick Ratio: 8.24

Sales & Book Value

Annual Sales: $2.07 million
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: A$0.01 per share
Price / Book: N/A

Miscellaneous

Outstanding Shares: 245,980,000
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: 2.72

10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

Mr. Otto Leslie-Steven Buttula AIMM (Age 60)
B.Ec., Grad. Dip., MAICD, Executive Chairman
Comp: $182.32k
Mr. Guy Carisbrooke
Financial Controller
Ms. Andrea Steele LLB B Com LLM
General Counsel & Joint Company Secretary
Ms. Elena Deak
Chief Commercial Officer
Mr. James Stephen Barrie CPA
Joint Company Secretary

Key Competitors

View All Competitors

Insiders

This page (ASX:RHY) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Rhythm Biosciences (RHY) Stock Price, News & Analysis

About Rhythm Biosciences Stock (ASX:RHY)

RHY Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info